Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $959764.0.

  • Prokidney's Gains from Sales and Divestitures fell 2819.21% to $959764.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $959764.0, marking a year-over-year decrease of 2819.21%. This contributed to the annual value of $1.3 million for FY2024, which is 4101.89% down from last year.
  • As of Q3 2025, Prokidney's Gains from Sales and Divestitures stood at $959764.0, which was down 2819.21% from $959764.0 recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Gains from Sales and Divestitures peaked at $2.3 million during Q3 2023, and registered a low of $949678.0 during Q1 2025.
  • Over the past 4 years, Prokidney's median Gains from Sales and Divestitures value was $1.3 million (recorded in 2024), while the average stood at $1.5 million.
  • Per our database at Business Quant, Prokidney's Gains from Sales and Divestitures soared by 6589.48% in 2023 and then crashed by 4154.92% in 2024.
  • Prokidney's Gains from Sales and Divestitures (Quarter) stood at $1.7 million in 2022, then skyrocketed by 30.67% to $2.3 million in 2023, then tumbled by 41.02% to $1.3 million in 2024, then decreased by 28.19% to $959764.0 in 2025.
  • Its last three reported values are $959764.0 in Q3 2025, $959764.0 for Q2 2025, and $949678.0 during Q1 2025.